Forbes contributors publish independent expert analyses and insights. Expert in AI for healthcare and longevity biotechnology Sep 27, 2023, 12:53pm EDT This article is more than 2 years old. The ...

Steven Paul’s “How to improve R&D productivity: the pharmaceutical industry's grand challenge” published in Nature Reviews Drug Discovery in 2010 is one of the highest cited and most frequently quoted ...

With manufacturing onshoring a continuing point of discussion in the industry, many pharma companies went the opposite way for R&D in 2025, deciding to conduct innovation overseas. According to a ...

Pharma’s return on investment (ROI) for research and development (R&D) is seeing a comeback after a record low in 2022, according to a recent report out of Deloitte. ROI on pharma R&D jumped to 4.1% ...

Another R&D budget ranking has arrived, and Roche remains the top dog among the world’s largest pharmaceutical companies. Roche spent 14.05 billion Swiss francs on R&D in 2022, or roughly $15.15 ...

While the return on R&D investment from biopharma companies has been a disappointment since 2010 -- with a notable exception in 2020 and 2021 due to COVID-19 -- productivity appears to have turned a ...

Ozmosi and Planview have partnered to integrate structured clinical datasets with AI-driven portfolio planning in pharmaceutical R&D. The collaboration aims to connect external scientific intelligence ...

Circle Pharma, a clinical-stage biopharmaceutical company dedicated to discovering and developing cell-permeable macrocycles as a new class of therapies, today announced the successful closing of a ...